AMX0035 Approved!
Podcast |
Connecting ALS
Publisher |
ALS Association
Media Type |
audio
Categories Via RSS |
Health & Fitness
Society & Culture
Publication Date |
Oct 06, 2022
Episode Duration |
00:11:30

This week, Jeremy talks to Calaneet Balas, President and CEO of The ALS Association about the approval of RELYVRIO, formerly known as AMX0035, for the treatment of ALS and looks ahead to the fight for access to this and other ALS treatments in the pipeline.

 

Learn more about RELYVRIO at https://www.als.org/navigating-als/living-with-als/fda-approved-drugs/amx0035

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.

Welcome to Connecting ALS. This week, we discuss the approval of AMX0035.

This week, Jeremy talks to Calaneet Balas, President and CEO of The ALS Association about the approval of RELYVRIO, formerly known as AMX0035, for the treatment of ALS and looks ahead to the fight for access to this and other ALS treatments in the pipeline.

 

Learn more about RELYVRIO at https://www.als.org/navigating-als/living-with-als/fda-approved-drugs/amx0035

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review